Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruboxistaurin on Small Fiber Function in Diabetic Neuropathy
NCT00190970Phase 2Completed
- Sponsor
- Chromaderm
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruboxistaurin in diabetic peripheral neuropathy (DPN), sponsored by Chromaderm. Started Oct 2004; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00190970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190970.